Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients

Figure 2

Serum interleukin- (IL-) 2 receptor (IL-2R), IL-6, IL-10, and tumor necrosis factor- (TNF-) α levels in the liver dysfunction group, matched control group, and healthy volunteers.